The Cambridge Paediatric ECMC team is based at Addenbrooke’s Hospital. The Cambridge Biomedical Campus has grown up around Addenbrooke’s hospital, combining world-class research, patient care and education on a single site. Construction, on the campus, is about to start for Cambridge Children’s Hospital and the team will relocate there once it is open.
We are East Anglia’s Principal Treatment Centre for paediatric oncology and haematology. C2 is a 19-bedded inpatient ward and we have a dedicated oncology/haematology day unit for children 0-16 years of age. We also have a Teenage and Young Adult unit on site, with a TYA research nurse for this area. The TYA unit can cater for patients aged 14-24 years of age. We see approximately 150 children with a new malignant diagnosis per year, and a further 170 new cases of non-malignant haematology.
We have 5 paediatric oncology consultants, 2 academic paediatric oncology consultants, 3 paediatric haematologists and 1 paediatric palliative care consultant. Many of our consultant team lead on national and international clinical trials.
The paediatric oncology/haematology research team comprises of 2 WTE (whole-time equivalent) nurses (0.6 is ECMC funded), 2 data managers and a trials coordinator. We are embedded within the clinical paediatric oncology/haematology team and work closely with the nursing, medical and wider multi-disciplinary team. This promotes shared knowledge and best practice, ensuring high quality clinical research is conducted by staff with appropriate skills.
We currently have 20 research studies on our portfolio, with more in the pipeline, including several early phase studies.
We already aim to recruit all eligible patients to a trial, and offer biobanking all patients (whether on a trial or not). Our aim is to broaden the number of studies available; including offering more early phase clinical trials to the children of East Anglia.